^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Regimen:GVD (gemcitabine + pegylated liposomal doxorubicin + vinorelbine tartrate)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Hodgkin Lymphoma...Relapsed/Refractory Disease...Second-Line and Subsequent Therapy...GVD (gemcitabine, vinorelbine, liposomal doxorubicin)